Back to the main directory
Company Analysis / Equity
- Kape Technologies - Strong H1 performance by Edison Investment Research
- Morningstar | Upgrading Our Moat Rating and Increasing Our FVE for ConocoPhillips. See Updated Analyst Note from 24 Sep 2018 by Morningstar
- Morningstar | Comcast Wins Auction for Sky With Bid of GBX 1,728; May Have Found the Winner's Curse by Morningstar
- Morningstar | Comcast Wins Auction for Sky With Bid of GBX 1,728; May Have Found the Winner's Curse by Morningstar
- Morningstar | Comcast Wins Auction for Sky With Bid of GBX 1,728; May Have Found the Winner's Curse by Morningstar
- Bayer's strong competitive positioning in healthcare and crop science leads to a wide moat. by Morningstar
- With its competitive prowess, Clorox shouldn't be set back by cost and competitive headwinds. by Morningstar
- Morningstar | Bayer's strong competitive positioning in healthcare and crop science leads to a wide moat. by Morningstar
- New drug launches and less patent exposure should increase the growth outlook for the company. by Morningstar
- New drug launches and less patent exposure should increase the growth outlook for the company. by Morningstar
- Morningstar | New drug launches and less patent exposure should increase the growth outlook for the company. by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Upgrading Our Moat Rating and Increasing Our FVE for ConocoPhillips by Morningstar
- Morningstar | Upgrading Our Moat Rating and Increasing Our FVE for ConocoPhillips by Morningstar
- Morningstar | Comcast Wins Auction for Sky With Bid of GBX 1,728; May Have Found the Winner's Curse by Morningstar
- Morningstar | Comcast Wins Auction for Sky With Bid of GBX 1,728; May Have Found the Winner's Curse by Morningstar
- Morningstar | Comcast Wins Auction for Sky With Bid of GBX 1,728; May Have Found the Winner's Curse by Morningstar
- Bayer's strong competitive positioning in healthcare and crop science leads to a wide moat. by Morningstar
- Morningstar | Bayer's strong competitive positioning in healthcare and crop science leads to a wide moat. by Morningstar
- GMV Minerals Inc (TSXV: GMV) – Expands Resource by 22.5% / PEA Expected in October by Fundamental Research
- Morningstar | With its competitive prowess, Clorox shouldn't be set back by cost and competitive headwinds. by Morningstar
- Nordic Gold Corporation (TSXV: NOR / OTC: FIEIF / FSE: 2FN) – Amended Financing Agreement to Avoid Significant Share Dilution / Raising Fair Value by Fundamental Research
- Morningstar | New drug launches and less patent exposure should increase the growth outlook for the company. by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar
- Morningstar | EV Sales in China and the EU Will Accelerate, Driving Above-Consensus Global Adoption Rates by Morningstar